Observational studyInternational ophthalmology2025
Impact of the COVID-19 pandemic on the incidence and recurrence of central serous chorioretinopathy in Greece: a multicenter study.
Observational study in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the impact of the COVID-19 pandemic on the incidence and recurrence of central serous chorioretinopathy (CSCR) in Greece, analyzing data from 2017 to 2023.
methodsA retrospective, observational, cross-sectional study was conducted, including patients diagnosed with either new-onset or recurrent CSCR at five ophthalmology departments in Greece from January 2017 to December 2023. Data were categorized into "pre-COVID" (2017-2019) and "COVID" (2021-2023) periods, excluding cases from 2020 due to lockdown restrictions. Patient demographics, disease recurrence, and COVID-19 infection history were recorded. Statistical analyses included chi-square tests, Spearman's rank correlation, and Student's t-test.
resultsA total of 730 CSCR cases were analyzed (435 new-onset, 295 recurrent). The participants' mean age was 46.8 ± 7.5 years. The overall number of cases significantly increased during the COVID-19 period (462 cases) compared to the pre-COVID period (268 cases) (p < 0.001). Both new-onset (164 vs. 271, p < 0.001) and recurrent cases (104 vs. 191, p < 0.001) showed a significant rise. Among patients from 2021 to 2023, those with a confirmed COVID-19 infection had significantly higher CSCR rates compared to non-infected individuals (p < 0.001).
conclusionThe COVID-19 pandemic was associated with a significant increase in CSCR incidence and recurrence in Greece. This rise may be attributed to heightened psychological stress and endogenous cortisol elevation during the pandemic, as well as direct viral effects and corticosteroid use in infected patients. Further studies are needed to explore underlying mechanisms and long-term consequences.
Indexed as
Identifiers
40794340What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.